Navigation Links
Imagenetix Inc. Reports Third Fiscal Quarter Results
Date:2/13/2008

rants issued to marketing individuals related to the retail launch of Inflame Away, also there was $280,000 of increased payroll expense including $232,000 in non-cash compensation. These increases were offset by a $120,000 decrease in clinical research studies and $311,000 in reduced consulting fees.

Net loss for the three months was $(395,000) or $(0.04) per share compared to a loss of $(281,000) or $(0.03) per share for the same period of the prior fiscal year. The net loss for the nine month period was $(1,461,000) or $(0.13) per share compared to a loss of $(691,000) or $(0.06) per share in the prior fiscal period.

Commenting on the results of the quarter, Mr. William Spencer, Imagenetix's Chief Executive Officer said, "Although our retail launch has taken longer to implement than we had anticipated, we are starting to see a significant increase in demand for the product by retail customers. In addition we are in the process of increasing the number of retailers who will be carrying our product during our fourth fiscal quarter of 2008 and first fiscal quarter of 2009. Our advertorial approach utilizing, Tony Gwynn, has produced a dramatic impact on sales of our product in stores located in areas where the ads have been placed. These results have been instrumental in attracting additional retail locations."

Mr. Spencer added, "During the quarter we have made substantial progress on a number of other fronts and expect to see additional sales of other products, particularly in the Private Label area, in the near future."

During the quarter warrant holders with warrants scheduled to expire on October 23, 2007 were given the right to extend their warrants for three years for a warrant extension fee of $.05 per warrant share. Upon this extension the call provision was also changed to allow the Company to call the warrants if the stock should trade for 10 business days at a 20% premium to the adjusted conversion price.

As a result of
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
3. Imagenetix Reports Results of Offer to Extend Warrants
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... James Sherley says he has been working ... cell technology since his days as a principal investigator at ... late 1990’s. Sherley founded the ASCTC as a new ... the intellectual property developed in Sherley’s research over the years ... of Technology (MIT), and more recently as a senior scientist ...
(Date:10/30/2014)... UAE (PRWEB) October 30, 2014 Grace Century ... Dr. James A. Manganello, Chairman of the Board, to the ... Bahamas. The appointment was made by the Ministry of ... September 24th, 2014. , More than a year ... Research Bill , Prime Minister Perry Christie said the government ...
(Date:10/30/2014)... one of the key challenges in the development of ... physicists. , In a paper published today (28 October) ... colleagues show how to make a new type of ... devices, such as high-precision sensors and specialised superfast computers, ... But the methods for trapping these tiny particles are ...
(Date:10/27/2014)... 2014 The Italian company ... and sell its artificial "lower limb", after the ...      (Photo: http://photos.prnewswire.com/prnh/20141027/713097 ) ... the definitive judgement has arrived: Roadrunnerfoot, the small ... accessible hi-tech prostheses with composite materials, has won ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2
... ... space, ... the newest member of its surface disinfection line,CaviWipes in a flat ... slim, flexible packaging and,adhesive-backed strips. Each flat pack contains convenient, durable,nonwoven, ...
... Pharmaceuticals,a division of Wyeth (NYSE: WYE ), ... (FDA) has approved PRISTIQ(TM) (desvenlafaxine), a,structurally novel, once-daily ... major depressive disorder (MDD). Wyeth,expects to begin shipping ... 2008., "We are pleased to be able ...
... Asbestos-Cancer Group: CNN Expose Highlights Urgent Need for ... ... CNN,s recent expose on,asbestos in children,s toys demonstrates the shocking reality ... decades, asbestos was used heavily in Navy ships and shipyards; in,workplaces; ...
Cached Biology Technology:CaviWipes(R): Taking Surface Disinfection to a New Level 2FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 2FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 3FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 4FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 5FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 6FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 7FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 8FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 9Calling for a Cure 2
(Date:10/31/2014)... Geologists are letting the air out of a nagging mystery ... have long speculated as to why animal species didn,t flourish ... to prosper at the end of the Proterozoic period, about ... stretch before that, when most researchers think there also was ... so great then, after all. , In a study published ...
(Date:10/31/2014)... University of Adelaide-led project has developed a new test ... against the H5N1 strain of avian influenza virus or ... , This is a significant step in the fight ... is widespread in the poultry populations of South East ... concern because of its possible transmission to humans and ...
(Date:10/30/2014)... Mich. – When most animals begin life, cells immediately ... a vital organ. However, mammals, including humans, are special. ... different first choice – to become the protective placenta ... during this critical first step that research from Michigan ... in the current issue of PLOS Genetics ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2New step towards eradication of H5N1 bird flu 2Identifying the source of stem cells 2
... Biobanks are repositories for tissue samples, usually in ... from surgical procedures. These samples are collected and used ... linked to personal health information regarding the sample donor. ... researchers who want to use them face important questions ...
... The Life Sciences Discovery Fund (LSDF) today announced awards ... therapies and key resources for medical researchers and health-care ... the three programs. The programs will be led ... across the state. Dr. David Flum will work with ...
... MADISON, WI, JUNE 28, 2011 -- The ... provides information needed to sustainably manage agroforestry systems. ... increase yields and also reduce financial and environmental ... that allows for site-specific evaluation of nutrient-production imbalances ...
Cached Biology News:Public prefers limited informed consent process for biobanks 2Public prefers limited informed consent process for biobanks 3Life Sciences Discovery Fund helps launch 3 programs to advance health research and development 2Analyzing agroforestry management 2
... assays utilize the membrane-permeant ester forms ... charged fluorescent beta-lactamase substrates, CCF2 and ... the cell, where cleavage by endogeneous ... their negatively charged forms, thereby trapping ...
... utilize the membrane-permeant ester forms (CCF2-AM ... fluorescent beta-lactamase substrates, CCF2 and CCF4. ... cell, where cleavage by endogeneous cytoplasmic ... negatively charged forms, thereby trapping them ...
1M stock solution (238mg/ml)...
Request Info...
Biology Products: